940 related articles for article (PubMed ID: 15853597)
1. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
4. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
Lee M; Aronne LJ
Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
6. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
Schernthaner GH; Schernthaner G
Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
Lebovitz HE
Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular manifestations of insulin resistance.
Chahwala V; Arora R
Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
Caballero AE
Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
[TBL] [Abstract][Full Text] [Related]
11. [Adipocytokins, obesity and development of type 2 diabetes].
Lacquemant C; Vasseur F; Leprêtre F; Froguel P
Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
Rader DJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
[TBL] [Abstract][Full Text] [Related]
13. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
Reddy KJ; Singh M; Bangit JR; Batsell RR
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
McLaughlin T; Abbasi F; Lamendola C; Reaven G
Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation.
Caballero AE
Arch Med Res; 2005; 36(3):241-9. PubMed ID: 15925014
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
18. Role of adipocytokines in obesity-associated insulin resistance.
Zou C; Shao J
J Nutr Biochem; 2008 May; 19(5):277-86. PubMed ID: 18054218
[TBL] [Abstract][Full Text] [Related]
19. The endothelial dysfunction in diabetes mellitus.
Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P; Ghanim H; Chaudhuri A; Mohanty P
J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
